How many years of comparable data are there for Lithuania and Saint Vincent and the Grenadines?

6 years are reported by both, from 2000 to 2021.

Where does this data come from?

Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, female (% of total female deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Lithuania vs Saint Vincent and the Grenadines: Cause of death, by non-communicable diseases, ages 60+, female

Lithuania

81.1%

in 2021

Saint Vincent and the Grenadines

80.6%

in 2021

Lithuania rank

48th

Saint Vincent and the Grenadines rank

50th

Cause of death, by non-communicable diseases, ages 60+, female over time

Lithuania
Saint Vincent and the Grenadines

How they compare

Lithuania currently reports 81.1% against 80.6% in Saint Vincent and the Grenadines, a difference of 0.5%.

Across all 6 years both countries report, Lithuania has been ahead every year.

Lithuania ranks 48th and Saint Vincent and the Grenadines ranks 50th of 185 countries.

Lithuania has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade	Lithuania	Saint Vincent and the Grenadines	Difference	Ahead
2000s	96.1%	89.7%	6.4%	Lithuania
2010s	95.6%	88.3%	7.3%	Lithuania
2020s	85.8%	84.6%	1.2%	Lithuania

Averages of every year both report within each decade.

Frequently asked questions

Which has higher cause of death, by non-communicable diseases, ages 60+, female, Lithuania or Saint Vincent and the Grenadines?: Lithuania, at 81.1% against 80.6% in Saint Vincent and the Grenadines as of 2021.
What is the difference in cause of death, by non-communicable diseases, ages 60+, female between Lithuania and Saint Vincent and the Grenadines?: 0.5%, with Lithuania ahead.
How many years of comparable data are there for Lithuania and Saint Vincent and the Grenadines?: 6 years are reported by both, from 2000 to 2021.
How do Lithuania and Saint Vincent and the Grenadines rank globally for cause of death, by non-communicable diseases, ages 60+, female?: Lithuania ranks 48th and Saint Vincent and the Grenadines ranks 50th of 185 countries.
Where does this data come from?: Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, female (% of total female deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Lithuania vs Saint Vincent and the Grenadines: Cause of death, by non-communicable diseases, ages 60+, female. Statizoid, drawing on Global Health Estimates, World Health Organization (WHO). Retrieved 18 September 2026, from https://health.statizoid.com/compare/cause-of-death-by-non-communicable-diseases-ages-60-female-percent-of-total-female-deaths/lithuania/st-vincent-and-the-grenadines/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/cause-of-death-by-non-communicable-diseases-ages-60-female-percent-of-total-female-deaths/lithuania/st-vincent-and-the-grenadines/">Lithuania vs Saint Vincent and the Grenadines: Cause of death, by non-communicable diseases, ages 60+, female</a> — Statizoid

About this data

Indicator: Cause of death, by non-communicable diseases, ages 60+, female (% of total female deaths ages 60+)
Unit: % of total female deaths ages 60+
Source: Global Health Estimates, World Health Organization (WHO)
Licence: CC BY 4.0 (World Bank Open Data)
Coverage: 232 places, 1,392 data points, 2000–2021
Last refreshed: 18 September 2026

Number of female deaths ages 60+ due to non-communicable diseases divided by number of all female deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.